Compound library / Diabetes
SGLT2 inhibitor that lowers blood sugar by causing the kidneys to excrete excess glucose in urine; also has demonstrated heart failure and kidney-protective benefits independent of diabetes.
| Category | Diabetes |
|---|---|
| Typical route | Oral |
| Half-life | ~12-13 hours |
| Common dose range | 10-25 mg once daily |
| Typical cycle length | Ongoing, long-term |
BioHack Track models Empagliflozin (Jardiance) at a half-life of 12.5 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Oral tablet; no reconstitution needed.
Store at room temperature.
Prescription medication. Increases risk of genital yeast/urinary infections and rare but serious euglycemic ketoacidosis; can cause dehydration — fluid intake matters.
Track Empagliflozin (Jardiance) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Empagliflozin (Jardiance) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.